DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Durect Corporation (DRRX)
« Back to company indexDRRX Chatter Timeline
Stock Ticker for DRRX
Most Active Tweeters for DRRX
| User | Tweets |
|---|---|
| @BlueBioNow | 5 |
| @Gambiste1 | 5 |
| @AmericanBanking | 4 |
| @newsfilterio | 3 |
| @TickerReport | 3 |
Recent Tweets for DRRX
 |
@BioBreakout $DRRX Bollinger Band Sqeeeeeze... https://t.co/YjRcNbYg8s November 10th 2019, 3:11pm |
 |
@Gambiste1 RT @Tommycoulter4: Key events next week - healthcare | Seeking Alpha $DRRX https://t.co/7Grxs3cB6j November 10th 2019, 2:11pm |
|
@Gambiste1 RT @stocks_sports: Key events next week - healthcare | Seeking Alpha $DRRX https://t.co/oL63VQauFI November 10th 2019, 2:11pm |
 |
@Tommycoulter4 Key events next week - healthcare | Seeking Alpha $DRRX https://t.co/7Grxs3cB6j November 10th 2019, 2:11pm |
 |
@stocks_sports Key events next week - healthcare | Seeking Alpha $DRRX https://t.co/oL63VQauFI November 10th 2019, 2:11pm |
 |
@WeekHerald DURECT Co. $DRRX Expected to Announce Quarterly Sales of $10.38 Million https://t.co/2mKcJgUGJn November 10th 2019, 6:11am |
 |
@OlympiaReport Zacks: Brokerages Anticipate DURECT Co. $DRRX Will Post Quarterly Sales of $10.38 Million https://t.co/63Hq0hYkj4 November 10th 2019, 6:11am |
 |
@AmericanBanking Zacks: Brokerages Anticipate DURECT Co. $DRRX Will Post Quarterly Sales of $10.38 Million https://t.co/eSxHQUo7TB #stocks November 10th 2019, 6:11am |
 |
@BlueBioNow $DRRX substantial stock price changes 2.15 % change recently https://t.co/7HeBMHCdbk November 10th 2019, 3:11am |
 |
@WatchlistN -$0.01 Earnings Per Share Expected for DURECT Co. $DRRX This Quarter https://t.co/OACelkY3HA November 8th 2019, 5:11pm |
 |
@TickerReport -$0.01 Earnings Per Share Expected for DURECT Co. $DRRX This Quarter https://t.co/YB8DVHrhhe November 8th 2019, 5:11pm |
|
@AmericanBanking -$0.01 Earnings Per Share Expected for DURECT Co. $DRRX This Quarter https://t.co/z40Admw6dc #stocks November 8th 2019, 5:11pm |
 |
@chartseer RT @kkernttb: $DRRX a nice looking small cap setup... nice coil and expanding volume last hour or so https://t.co/9mM4m4Khdb November 8th 2019, 3:11pm |
 |
@kkernttb $DRRX a nice looking small cap setup... nice coil and expanding volume last hour or so https://t.co/9mM4m4Khdb November 8th 2019, 3:11pm |
|
@Gambiste1 RT @jjokerst: $DRRX coiling prior to 11/12 phase 2 data release for alcoholic hepatitis treatment. #fda November 7th 2019, 10:11pm |
 |
@jjokerst $DRRX coiling prior to 11/12 phase 2 data release for alcoholic hepatitis treatment. #fda November 7th 2019, 8:11pm |
 |
@newsfilterio Durect EPS beats by $0.01, beats on revenue $DRRX https://t.co/3RjfDAWBy6 November 7th 2019, 3:11pm |
|
@newsfilterio DURECT Corporation Announces Third Quarter 2019 Financial Results and Update of Programs $DRRX https://t.co/zDMBYuQFEc November 7th 2019, 2:11pm |
 |
@dispatchtribune DURECT $DRRX Issues Earnings Results, Misses Expectations By $0.03 EPS https://t.co/YbFTgtFlfF November 7th 2019, 12:11pm |
 |
@EnterpriseLeade DURECT $DRRX Issues Earnings Results https://t.co/2aazpvtZXT November 7th 2019, 11:11am |
 |
@bmarckxCFA $DRRX DURECT to Host Key Opinion Leader Call on DUR-928 Phase 2a Alcoholic Hepatitis Study Results https://t.co/uqjHGO2u5m via @YahooFinance November 7th 2019, 8:11am |
|
@Gambiste1 RT @knackchamp: $DRRX Nice consolidation period, RSI and CCI showing uptrend. This could see 2.40+ on break of 2.05 area. #TradeSmart https… November 7th 2019, 1:11am |
 |
@knackchamp $DRRX Nice consolidation period, RSI and CCI showing uptrend. This could see 2.40+ on break of 2.05 area.… https://t.co/KQKLoLLMKV November 7th 2019, 12:11am |
 |
@AlertTrade RT @Briefingcom: $DRRX: Durect to host key opinion leader conference call and live webcast to discuss results of its recently... https://t.… November 6th 2019, 7:11pm |
 |
@Briefingcom $DRRX: Durect to host key opinion leader conference call and live webcast to discuss results of its recently... https://t.co/MPruAVYedp November 6th 2019, 7:11pm |
|
@newsfilterio DURECT to Host Key Opinion Leader Call on DUR-928 Phase 2a Alcoholic Hepatitis Study Results $DRRX https://t.co/0USGnTA2kg November 6th 2019, 7:11pm |
 |
@MaisaCorp $DRRX Host Key Opinion Leader Call on DUR-928 Phase 2a Alcoholic Hepatitis Study ResultsCall will feature data from… https://t.co/sgRMPH4H9k November 6th 2019, 7:11pm |
 |
@ProTradersNews $DRRX: DURECT to Host Key Opinion Leader Call on DUR-928 Phase 2a …: https://t.co/rARTkDyqB1 November 6th 2019, 6:11pm |
 |
@otcdynamics $DRRX DURECT to Host Key Opinion Leader Call on DUR-928 Phase 2a Alcoholic Hepatitis Study Results https://t.co/UeMWbQKU2l November 6th 2019, 6:11pm |
 |
@ez_alertz $DRRX DURECT to Host Key Opinion Leader Call on DUR-928 Phase 2a Alcoholic Hepatitis Study Results https://t.co/TEk5ADyzUr November 6th 2019, 5:11pm |
 |
@VGaykin RT @TraderTexMex: $DRRX DURECT to Host Key Opinion Leader Call on DUR-928 Phase 2a Alcoholic Hepatitis Study Results Nov 12th at 830am November 6th 2019, 5:11pm |
 |
@TraderTexMex $DRRX DURECT to Host Key Opinion Leader Call on DUR-928 Phase 2a Alcoholic Hepatitis Study Results Nov 12th at 830am November 6th 2019, 5:11pm |
 |
@ZolmaxNews DURECT $DRRX Issues Quarterly Earnings Results, Misses Estimates By $0.03 EPS https://t.co/aeNo5hk4EW November 6th 2019, 10:11am |
|
@Gambiste1 RT @LifeSciAdvisors: DURECT Corporation $DRRX Announces Third Quarter 2019 Financial Results and Update of Programs https://t.co/wIsIAJECSW November 5th 2019, 6:11pm |
 |
@LifeSciAdvisors DURECT Corporation $DRRX Announces Third Quarter 2019 Financial Results and Update of Programs https://t.co/wIsIAJECSW November 5th 2019, 12:11pm |
|
@WeekHerald DURECT $DRRX Releases Earnings Results, Misses Estimates By $0.03 EPS https://t.co/gJDvgwjxg6 November 5th 2019, 11:11am |
 |
@bbnsnews DURECT $DRRX Posts Earnings Results, Misses Expectations By $0.03 EPS https://t.co/6qqXcbAZzh November 5th 2019, 11:11am |
|
@TickerReport DURECT $DRRX Announces Earnings Results, Misses Estimates By $0.03 EPS https://t.co/Ul6OJIgRP5 November 5th 2019, 10:11am |
|
@AmericanBanking DURECT $DRRX Releases Quarterly Earnings Results, Misses Estimates By $0.03 EPS https://t.co/D97QB9ddxe #stocks November 5th 2019, 9:11am |
 |
@ConsumerFeed DURECT $DRRX Releases Quarterly Earnings Results, Misses Estimates By $0.03 EPS https://t.co/LbK43HZd9p November 5th 2019, 9:11am |
|
@BlueBioNow $DRRX might be worth taking a position when this bottoms 4.08 % change recently https://t.co/7HeBMHCdbk November 5th 2019, 6:11am |
 |
@SiteFocusHQ $DRRX Earnings Intelligence Analysis of recent earnings identified Durect Corporation (NASDAQ: DRRX ) business focu… https://t.co/EOv19bukrH November 4th 2019, 11:11pm |
 |
@StockNewsNow $DRRX DURECT Corporation Announces Third Quarter 2019 Financial Results and Update of Programs https://t.co/yLCqXg2i0R November 4th 2019, 11:11pm |
|
@ProTradersNews $DRRX: DURECT Corp (DRRX) CEO James Brown on Q3 2019 Results …: https://t.co/SX7sWcJC8r November 4th 2019, 10:11pm |
 |
@SeekingAlpha $DRRX - DURECT Corp (DRRX) CEO James Brown on Q3 2019 Results - Earnings Call Transcript. Read more and get updates… https://t.co/KFzyhBaEbW November 4th 2019, 9:11pm |
 |
@Stock_News_Now $DRRX: New SEC Filing for DRRX: Form 8-K (No. 0001564590-19-039797): https://t.co/jklLqpkm5z November 4th 2019, 4:11pm |
|
@MaisaCorp $DRRX have completed enrollment in a Phase 2a, randomized, double-blind, vehicle-controlled proof-of-concept clinic… https://t.co/YQkU3990zg November 4th 2019, 4:11pm |
|
@otcdynamics $DRRX DURECT Corporation Announces Third Quarter 2019 Financial Results and Update of Programs https://t.co/evVXkxOSKT November 4th 2019, 4:11pm |
 |
@ProVesting $DRRX: DURECT Corporation Announces Third Quarter 2019 Financial …: https://t.co/tst3PDxuf0 November 4th 2019, 4:11pm |
 |
@MarketCurrents $DRRX - Durect EPS beats by $0.01, beats on revenue https://t.co/UfvtU2gXkS November 4th 2019, 4:11pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.